Knocking out ITGA4 restored the sensitivity of BCR-ABL+ murine leukemia toward nilotinib (NTB), and a blockade of integrin alpha 4 with a monoclonal antibody sensitized primary B-ALL engrafted xenograft mice to chemotherapy (175). This evidence concerns the gene ITGA4 and acute lymphoblastic leukemia.